Clinical Trials Browser

Phase 1 × Multiple Myeloma × etoposide phosphate × Clear all

NCT00005792 2019-11-08

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Phase 1 Completed

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00477035 2017-01-11

Post-transplant Autologous Cytokine-induced Killer (CIK) Cells for Treatment of High Risk Hematologic Malignancies

Phase 1 Completed

Other hematologic neoplasmPlasma cell

Leukemia, Multiple Myeloma